A detailed history of Wfa Of San Diego, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wfa Of San Diego, LLC holds 150 shares of GILD stock, worth $13,887. This represents 0.01% of its overall portfolio holdings.

Number of Shares
150
Previous 150 -0.0%
Holding current value
$13,887
Previous $10,000 20.0%
% of portfolio
0.01%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$76.01 - $86.7 $11,401 - $13,005
150 New
150 $11,000
Q4 2022

Jan 31, 2023

BUY
$62.32 - $89.47 $94,103 - $135,099
1,510 New
1,510 $129,000
Q2 2022

Jul 28, 2022

BUY
$57.72 - $65.01 $87,157 - $98,165
1,510 New
1,510 $93,000
Q1 2022

Apr 25, 2022

SELL
$57.92 - $72.58 $90,644 - $113,587
-1,565 Closed
0 $0
Q3 2021

Oct 25, 2021

SELL
$67.69 - $73.03 $130,709 - $141,020
-1,931 Reduced 55.23%
1,565 $109,000
Q2 2020

Aug 18, 2020

BUY
$72.34 - $84.0 $252,900 - $293,664
3,496 New
3,496 $219,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Wfa Of San Diego, LLC Portfolio

Follow Wfa Of San Diego, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wfa Of San Diego, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wfa Of San Diego, LLC with notifications on news.